Compounding Resources during COVID-19 Pandemic (Updated March 25, 2020)
- March 12, 2020 – The Appeals Panel issues decisions on the Appeals to USP <795>, <797>, and <825>. Click here for more information.
- The currently official versions of General Chapter <795> (last revised in 2014) and General Chapter <797> (last revised in 2008) remain official.
- General Chapter <825> will become official on a new date to be determined by the Chemical Medicines 4 Expert Committee. The official date will allow at least another six-month implementation period.
- General Chapter <800> became official on December 1, 2019. General Chapter <800> remains informational and not compendially applicable.
- Sign up for USP Healthcare Quality & Safety Updates
Millions of prescriptions are compounded by pharmacists, nurses, and doctors each year in the US to meet the unique needs of patients who otherwise may not have access to the required medicine in the right concentration or dosage. Understanding of the risks inherent in compounding and incorporating established USP standards into everyday practice is essential for patient safety.
To learn more about compounding and available resources click here.